Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q17
SBA

SBA — Single Best Answer · Review

Question 17

Feto-maternal medicine → Perinatology

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID 229d78fd-d250-48c4-8af9-defa27da839d

Classification

Speciality
Obstetrics and Gynaecology
Group
Clinical
Title
Feto-maternal medicine
Topic
Perinatology
Subtopic 1
Diagnosis
Subtopic 2
Invasive
Subtopic 3
CVS
Question Type
SBA

Question

SSBA
Question Header
Prenatal diagnosis
Question Stem
A pregnant woman at 12+2 weeks of gestation has received a high-risk screening result for a chromosomal abnormality. Following counselling, she wishes to have a definitive prenatal diagnostic test as soon as possible. Which is the most appropriate investigation?

Options

A Amniocentesis at 12+2 weeks
B Amniocentesis at 14+0 weeks
C Chorionic villus sampling at 12+2 weeks
D Defer invasive testing until 15+0 weeks
E Repeat screening instead of offering diagnostic testing

Explanation

Chorionic villus sampling (CVS) is an appropriate definitive prenatal diagnostic procedure at 12+2 weeks. RCOG states that CVS should not be performed before 10+0 weeks and, where possible, should be performed from 11+0 weeks onwards because procedures at earlier gestations may be technically more challenging. Amniocentesis should not be performed before 15+0 weeks because early amniocentesis is associated with an increased risk of pregnancy loss and fetal talipes. Therefore, for a woman at 12+2 weeks who wishes to proceed with definitive invasive prenatal diagnosis without unnecessary delay, CVS is the appropriate procedure.

Option Validity

A) Amniocentesis should not be performed before 15+0 weeks.

B) Amniocentesis at 14+0 weeks is still earlier than the recommended minimum gestation.

D) Waiting until 15+0 weeks is unnecessary when CVS is an appropriate diagnostic option at this gestation.

E) Further screening does not provide the definitive diagnostic information requested by the woman.

Further Reading

Navaratnam K, Alfirevic Z; Royal College of Obstetricians and Gynaecologists. Amniocentesis and chorionic villus sampling: Green-top Guideline No. 8. BJOG. 2022;129:e1-e15. doi:10.1111/1471-0528.16821.

Source & metrics

Authored Difficulty
4.00
Evaluation Score
9.50
Destination
Site
Source
Amniocentesis and chorionic villus sampling: Green-top Guideline No. 8
Source Section
Timing of amniocentesis and chorionic villus sampling
Source Locator
RCOG Green-top Guideline No. 8, October 2021
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question